L&C Bio's Q1 2026 Operating Profit Soars 647%… Record Earnings
-
Preliminary Q1 2026 results: Revenue KRW 23.8B (QoQ +15.2%, YoY +63.4%)
-
Operating profit KRW 6.5B (QoQ +165.5%, YoY +546.8%) showing significant growth
-
Pre-tax profit from continuing operations KRW 3.9B, turning to profit from a loss of KRW 20.4B in the previous quarter
-
Net income KRW 3.3B (QoQ +2.1%, YoY +400.6%)
-
These are preliminary unaudited figures subject to change after external audit review
KOSDAQ Filing Information
-
Filing: Preliminary Operating Results (Fair Disclosure)
-
Company: L&C BIO (290650)
-
Submission: L&C BIO Co., Ltd
-
Receipt: 05-11-2026
-
Under KRX KOSDAQ Market Division